Psoriasis Club
  • Forum
  • Home
  • Portal
  • Member List
  • Psoriasis Score
  • PQOLS
  • What is psoriasis
  • Search
  • Help
Hello Guest, Welcome To The Psoriasis Club Forum. We are a self funded friendly group of people who understand.
Never be alone with psoriasis, come and join us. (Members see a lot more than you)
wave
Login Register
Login
Username:
Password:
Lost Password?
 
Psoriasis Club › HealthHealth Boards › Psoriasis In The News v
« Previous 1 … 38 39 40 41 42 … 54 Next »

Psoriasis patients on Methotrexate could have undetected liver fibrosis

Threaded Mode
Psoriasis patients on Methotrexate could have undetected liver fibrosis
Fred Online
I Wanted To Change the World But Got Up Far Too Late.
Moderator
Posts: 66,926
Threads: 3,887
Joined: Aug 2011
Gender: Male
Location: France
Psoriatic Arthritis Score: 1
PQOLS: 1
Treatment: Bimzelx / Coconut Oil
#1
News  Fri-20-06-2014, 11:53 AM
This study tried to evaluate the diagnostic accuracy of noninvasive methods to detect fibrosis compared with liver biopsy (reference standard) in people with psoriasis taking Methotrexate, and suggests that larger prospective studies are required in this population to validate newer non-invasive methods.

Quote:
People with psoriasis taking methotrexate may be at increased risk of developing liver fibrosis compared with the general population. Noninvasive methods of detecting fibrosis have been widely adopted but their clinical utility is uncertain.

To evaluate the diagnostic accuracy of noninvasive methods to detect fibrosis compared with liver biopsy (reference standard) in people with psoriasis taking methotrexate.

A systematic search using Ovid/Medline, Embase, Cumulative Index to Nursing and Allied Health Literature, the Cochrane Library and Clinical Trials Register was performed. Diagnostic cohorts or case–control studies of adults taking or being considered for methotrexate therapy were considered.

Study quality was evaluated using the Quality Assessment tool for Diagnostic Accuracy Studies (QUADAS-2). Pooled data analysis was performed using RevMan 5.1. Bayesian meta-analysis was conducted using Markov chain Monte Carlo simulation. Seventeen studies were included. Sensitivity and specificity were 38% and 83% for standard liver function tests (LFTs), 74% and 77% for procollagen-3 N-terminal peptide (P3NP), 60% and 80% for Fibroscan, and 55% and 49% for ultrasound.

Confidence in these results is limited owing to low-quality data; old, small studies displayed significant selection bias and significant variation in the prevalence of fibrosis. No studies were identified evaluating recently developed markers. The clinical utility of LFTs, P3NP and liver ultrasound is poor.

Therefore if these tests are used in isolation, a significant proportion of patients with liver fibrosis may remain unidentified. Larger prospective studies are required in this population to validate newer non-invasive methods.

Source: NO LINKS ALLOWED
Quote
« Next Oldest | Next Newest »


Possibly Related Threads…
Thread Author Replies Views Last Post
News Tremfya and liver fibrosis progression with psoriasis Fred 3 483 Sat-19-04-2025, 14:28 PM
Last Post: Kat
News Three amino acids could help psoriasis Fred 2 412 Tue-15-04-2025, 11:43 AM
Last Post: Fred
News Could c-reactive protein predict psoriatic arthritis Fred 7 1,106 Mon-07-04-2025, 13:15 PM
Last Post: Forest Walker
News Living bioelectronics could possibly help psoriasis Fred 6 3,338 Sun-02-06-2024, 18:22 PM
Last Post: Caroline
News Psoriasis and liver problems Fred 6 5,630 Mon-08-01-2024, 02:10 AM
Last Post: Kat



Users browsing this thread: 1 Guest(s)
    About | Contact us | Login | Register | Home | Cookies/GDPR | RSS Syndication | Portal | Types Of Psoriasis | Psoriasis Score | Members Only Boards
    Copyright © 2010 - 2025 Psoriasis Club | All Rights Reserved | Founded May 2010 | Psoriasis Club Is Self Funded Without Sponsors Or Donations | Software by MyBB | Social
Linear Mode
Threaded Mode